Positive labeling with four neuroendocrine markers including Syn, CD56, NSE and CgA was apparent in these cases, which was similar to previous reports of esophageal SCC [28,30] and pulmonary SCC [2]. This evidence concerns the gene ENO2 and esophageal squamous cell carcinoma.